Successful management of delirium with dexmedetomidine in a patient with haloperidol-induced neuroleptic malignant syndrome: A case report

doi:10.12998/wjcc.v10.i2.625

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 10, Issue 2

This Article

Academic Content and Language Evaluation of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (3341)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-3) series.

Item

Count

PDF

291

WORD

HTML

1747

Figures (1-3)

427

Sum=2556

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

270

Download

515

Sum=785

Jan 14, 2022 (publication date) through Oct 2, 2024

Times Cited of This Article

Times Cited (4)

Journal Information of This Article

Publication Name

World Journal of Clinical Cases

ISSN

2307-8960

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Case Report

World J Clin Cases. Jan 14, 2022; 10(2): 625-630
Published online Jan 14, 2022. doi: 10.12998/wjcc.v10.i2.625

Full Size Figure Download Figure

Figure 3 Timeline depicting the onset of lorazepam-induced delirium followed by the development of neuroleptic malignant syndrome. CK: Creatine kinase; RASS: Richmond agitation-sedation scale; ICU: Intensive care unit.

Citation: Yang CJ, Chiu CT, Yeh YC, Chao A. Successful management of delirium with dexmedetomidine in a patient with haloperidol-induced neuroleptic malignant syndrome: A case report. World J Clin Cases 2022; 10(2): 625-630
URL: https://www.wjgnet.com/2307-8960/full/v10/i2/625.htm
DOI: https://dx.doi.org/10.12998/wjcc.v10.i2.625